Abstract:Background:It is generally assumed that once Antiphospholipid syndrome (APS) is diagnosed, patients should be treated with anticoagulation (ACO), possibly for a lifetime1.Objectives:Our main objective was the characterization of a group of patients with primary APS, evaluation of clinical profile, presence of APS antibodies (Ab) over time, recurrent thrombotic events and treatment.Methods:Demographic and clinical features of patients with APS were identified through the Unit’s database. APL significant titers … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.